Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$37,079
+$12,492 QoQ
Shares Held
516
+148.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,159
of 1,412 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GW&K Investment Management, LLC holds $191,069,124 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
567,421 | $95,633,135 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,037,242 | $48,242,125 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
3,171,113 | $31,711,130 | |
| 4 | ALKS |
Alkermes plc.
|
292,387 | $15,321,078 | |
| 5 | VTRS |
Viatris Inc
|
3,133 | $49,752 | |
| 6 | ZTS |
Zoetis Inc.
This page
|
516 | $37,079 | |
| 7 | HLN |
Haleon plc
|
3,796 | $35,416 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
495 | $16,770 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,079 | 516 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $24,587 | 208 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $27,428 | 218 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $47,554 | 325 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $45,381 | 291 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $50,712 | 308 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $50,019 | 307 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $59,786 | 306 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $47,674 | 275 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $41,287 | 244 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $33,947 | 172 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $24,879 | 143 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $21,698 | 126 | Shares | Sole | 2023-08-09 | |
| 2022-12-31 | $4,689 | 32 | Shares | Sole | 2023-02-10 | |
| 2022-06-30 | $260,757 | 1,517 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $197,830 | 1,049 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $11,225 | 46 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,077,671 | 5,551 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $9,122,135 | 48,949 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $15,048,158 | 95,556 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $19,853,214 | 119,959 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $19,825,878 | 119,888 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $16,588,006 | 121,045 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $12,074,758 | 102,598 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||